Back to CVE records
High 8.1Published Sep 15, 2026

CVE-2026-83357Vulnerability in the Oracle GraalVM for JDK, Oracle GraalVM product of Oracle Java SE (component: Compiler).

Updated under an hour ago ()

Does this affect you?

It affects Oracle Corporation Oracle GraalVM for JDK, Oracle GraalVM. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Vulnerability in the Oracle GraalVM for JDK, Oracle GraalVM product of Oracle Java SE (component: Compiler). The supported version that is affected is Oracle GraalVM for JDK 17: 23.0.13.1; Oracle GraalVM for JDK 21: 23.1.12.1; Oracle GraalVM: 25.0.4.1. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle GraalVM for JDK, Oracle GraalVM. Successful attacks of this vulnerability can result in takeover of Oracle GraalVM for JDK, Oracle GraalVM. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).

CVSS
8.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-22
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
oracle
NVD analysis
Awaiting Analysis
Record last updated
Sep 22, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Oracle Corporation Oracle GraalVM for JDK, Oracle GraalVM
oracle:graalvm_for_jdk_oracle_graalvm (from the name)
Oracle GraalVM for JDK 17:23.0.13.1; Oracle GraalVM for JDK 21:23.1.12.1; Oracle GraalVM:25.0.4.1
CNA record

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.